Clinical Trial Update: Instant Message-delivered Personalised Acceptance and Commitment Therapy (IMPACT) for Neuropsychiatric Symptoms in Persons With Mild Cognitive Impairment [NA]

View source ↗

Summary

This entry reports a clinical trial (IMPACT) delivering personalised Acceptance and Commitment Therapy via instant messaging to address neuropsychiatric symptom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Snippet

Sponsor: The University of Hong Kong | Conditions: Mild Cognitive Impairment (MCI) | NA | Status: RECRUITING